Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cat-PAD 5-year follow-on study in cat allergy
NCT02040844Phase 3Completed
- Sponsor
- NIOX Group
- Start
- Feb 2014
- Primary completion
- May 2017
- Modality
- Peptides
01
Overview
A Phase 3 trial of Cat-PAD in cat allergy, sponsored by NIOX Group. Started Feb 2014; status: completed.
02
Drugs
Cat-PAD
03
Conditions
cat allergy
Beyond the preview
Go deeper on NCT02040844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02040844.